Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
De Haar Research Task Force is a Netherlands-based clinical research organization (CRO) and site management organization (SMO) that specializes in conducting Phase II through Phase IV clinical trials. Established in 1996 and headquartered in Rotterdam, the organization provides a dedicated infrastructure for pharmaceutical and biotechnology sponsors to execute clinical studies across a variety of therapeutic areas, including cardiovascular, respiratory, and metabolic diseases. The foundation is recognized for its expertise in patient recruitment and high-quality study coordination within the Dutch medical system. By operating as an independent research site, De Haar Research Task Force streamlines the clinical development process for global drug developers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on De Haar Research Task Force.